Inovio Pharmaceuticals Inc (NASDAQ:INO)
| 0.551 Delayed Data As of Jun 08 |  -0.0301 / -5.18%Today’s Change | 0.55 Today|||52-Week Range 2.82 | -64.68% Year-to-Date |
Latest INO News | Press Releases
No recent news for Inovio Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.58 |
| Today’s open | 0.58 |
| Day’s range | 0.55 - 0.59 |
| Volume | 7,474,388 |
| Average volume (3 months) | 5,996,971 |
| Market cap | $150.6M |
Data as of 3:59pm ET, 06/08/2023
Growth & Valuation
| Earnings growth (last year) | +19.36% |
| Earnings growth (this year) | +51.79% |
| Earnings growth (next 5 years) | +41.52% |
| Revenue growth (last year) | +478.23% |
| P/E ratio | NM |
| Price/Sales | 36.27 |
| Price/Book | 0.65 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GTHXG1 Therapeutics Inc | -0.02 | -0.70% |
| --Immunovia AB (publ) | 0.00 | 0.00% |
| PRQRProQR Therapeutics N... | +0.01 | +0.86% |
| DRRXDURECT Corp | +0.32 | +5.89% |
Data as of 3:59pm ET, 06/08/2023
Financials
| Next reporting date | August 8, 2023 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $10.3M |
| Annual profit (last year) | -$279.8M |
| Net profit margin | -2,726.67% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Plymouth Meeting, Pennsylvania |
Forecasts
